RHHBYCongressional Stock Trades
Roche Holding AG
Drug Manufacturers - General
Congressional stock trades in Roche Holding AG (RHHBY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
4
Politicians Trading
3
Last Traded
Jul 11, 2025
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Bruce WestermanR | May 12, 2025 | Apr 21, 2025 | Sell | $1,001 - $15,000 | +52.53% |
| Bruce WestermanR | Apr 16, 2025 | Mar 3, 2025 | Buy | $1,001 - $15,000 | +41.48% |
Price History
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
3 members of Congress have disclosed 4 trades in Roche Holding AG (RHHBY). Most active: Bruce Westerman (2), Josh Gottheimer (1), Ritchie Torres (1).
Across all disclosures, members of Congress reported 1 purchases and 3 sales of Roche Holding AG (RHHBY). The most recent trade was on Jul 11, 2025.
Bruce Westerman disclosed buying Roche Holding AG (RHHBY) on Mar 3, 2025, valued at $1,001 - $15,000.
Ritchie Torres disclosed selling Roche Holding AG (RHHBY) on Jul 11, 2025, valued at $1,001 - $15,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.